F2R and breast cancer: To determine the potential of PAR1 as a useful prognostic factor for breast cancer patients, independent of the prognostic factors for tumour mortality; we compared the demographic, clinical, and pathological characteristics of the 29 PAR1-positive patients to those of the 21 PAR1-negative patients (Table 2).